| 1 |
Scarpellini E, Ang D, Pauwels A, et al. Management of refractory typical GERD symptoms [J]. Nat Rev Gastroenterol Hepatol, 2016, 13(5): 281-294.
|
| 2 |
Pearl J, Pauli E, Dunkin B, et al. SAGES endoluminal treatments for GERD [J]. Surg Endosc, 2017, 31(10): 3783-3790.
|
| 3 |
中华医学会消化病学分会. 2014年中国胃食管反流病专家共识意见[J].胃肠病学, 2015, 20(3): 155-168.
|
| 4 |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses [J]. Eur J Epidemiol, 2010, 25(9): 603-605.
|
| 5 |
Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease [J]. Surg Endosc, 2017, 31(12): 4865-4882.
|
| 6 |
Gregory D, Scotti DJ, Buck D, et al. Budget impact analysis to estimate the cost dynamics of treating refractory gastroesophageal reflux disease with radiofrequency energy: a payer perspective [J]. Manag Care, 2016, 25(5): 42-50.
|
| 7 |
Mattar SG, Qureshi F, Taylor D, et al. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass [J]. Surg Endosc, 2006, 20(6): 850-854.
|
| 8 |
Noar M, Squires P, Khan S. Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort [J]. Surg Endosc, 2017, 31(7): 2854-2862.
|
| 9 |
Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later [J]. Surg Endosc, 2014, 28(8): 2323-2333.
|
| 10 |
Liang WT, Wu JN, Wang F, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease [J]. Minerva Chir, 2014, 69(4): 217-223.
|
| 11 |
Liang WT, Wang ZG, Wang F, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study [J]. BMC Gastroenterol, 2014, 14: 178.
|
| 12 |
Reymunde A, Santiago N. Long-term results of radiofrequency energy delivery for the treatment of GERD: sustained improvements in symptoms, quality of life, and drug use at 4-year follow-up [J]. Gastrointest Endosc, 2007, 65(3): 361-366.
|
| 13 |
Hu ZW, Wang ZG, Zhang Y, et al. A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma [J]. Ann Surg Innov Res, 2014, 8: 3.
|
| 14 |
Liu HF, Zhang JG, Li J, et al. Improvement of clinical parameters in patients with gastroesophageal reflux disease after radiofrequency energy delivery [J]. World J Gastroenterol, 2011, 17(39): 4429-4433.
|
| 15 |
Liang WT, Yan C, Wang ZG, et al. Early and midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational study [J]. J Laparoendosc Adv Surg Tech A, 2015, 25(8): 657-661.
|
| 16 |
Mavrelis P, Aziz AMA, Rearick C, et al. Longer Term Clinical Outcomes after Radiofrequency Therapy for refractory Gastroesophageal Reflux Disease (GERD) [J]. Pract Gastroenterol, 2007, 31(10): 73-80.
|
| 17 |
Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure [J]. Gastrointest Endosc, 2007, 65(3): 367-372.
|
| 18 |
Viswanath Y, Maguire N, Obuobi RB, et al. Endoscopic day case antireflux radiofrequency (Stretta) therapy improves quality of life and reduce proton pump inhibitor (PPI) dependency in patients with gastroesophageal reflux disease: a prospective study from a UK tertiary centre [J]. Frontline Gastroenterol, 2019, 10(2): 113-119.
|
| 19 |
Nabi Z, Reddy DN. Update on Endoscopic Approaches for the Management of Gastroesophageal Reflux Disease [J]. Gastroenterol Hepatol (N Y), 2019, 15(7): 369-376.
|
| 20 |
Mermelstein J, Chait Mermelstein A, Chait MM. Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions [J]. Clin Exp Gastroenterol, 2018, 11: 119-134.
|
| 21 |
Gyawali CP, Roman S, Bredenoord AJ, et al. Classification of esophageal motor findings in gastroesophageal reflux disease: Conclusions from an international consensus group [J]. Neurogastroenterol Motil, 2017, 29(12).
|
| 22 |
Roman S, Gyawali CP, Savarino E, et al. Ambulatory reflux monitoring for diagnosis of gastroesophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group [J]. Neurogastroenterol Motil, 2017, 29(10): 1-15.
|
| 23 |
Yadlapati R, Tye M, Keefer L, et al. Psychosocial distress and quality of life impairment are associated with symptom severity in PPI non-responders with normal impedance-pH profiles [J]. Am J Gastroenterol, 2017, 113(1): 31-38.
|
| 24 |
Hussain ZH, Henderson EE, Maradey-Romerao C, et al. The proton pump inhibitor non-responder: a clinical conundrum [J]. Clin Transl Gastroenterol, 2015, 6(10): e115.
|
| 25 |
Yadlapati R, Vaezi MF, Vela MF, et al. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel [J]. Am J Gastroenterol, 2018, 113(7): 980-986.
|
| 26 |
Hillman L, Yadlapati R, Thuluvath AJ, et al. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease [J]. Dis Esophagus, 2017, 30(9): 1-15.
|
| 27 |
Kurlander JE, Kennedy JK, Rubenstein JH, et al. Patients' perceptions of proton pump inhibitor risks and attempts at discontinuation: a national survey [J]. Am J Gastroenterol, 2019, 114(2): 244-249.
|
| 28 |
Makunts T, Cohen IV, Awdishu L, et al. Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis [J]. Sci Rep, 2019, 9(1): 2282.
|
| 29 |
Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease [J]. Gastroenterol Rep, 2015, 3(1): 41-53.
|
| 30 |
Maret-Ouda J, Wahlin K, El-Serag HB, et al. Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux [J]. JAMA, 2017, 318(10): 939-946.
|
| 31 |
Yadlapati R, Hungness ES, Pandolfino JE. Complications of antireflux surgery [J]. Am J Gastroenterol, 2018, 113(8): 1137-1147.
|
| 32 |
Nicolau AE, Lobonţiu A, Constantinoiu S. New Minimally Invasive Endoscopic and Surgical Therapies for Gastroesophageal Reflux Disease (GERD) [J]. Chirurgia (Bucur), 2018, 113(1): 70-82.
|
| 33 |
Funk LM, Kanji A, Scott Melvin W, et al. Elective antireflux surgery in the US: an analysis of national trends in utilization and inpatient outcomes from 2005 to 2010 [J]. Surg Endosc, 2014, 28(5): 1712-1719.
|
| 34 |
Tebala GD. Gastroesophageal reflux disease. Are we acting in the best interest of our patients [J]? Eur Rev Med Pharmacol Sci, 2016, 20(21): 4553-4556.
|
| 35 |
Dughera L, Rotondano G, De Cento M, et al. Durability of Stretta radiofrequency treatment for GERD: results of an 8-year follow-up [J]. Gastroenterol Res Pract, 2014: 531907.
|